| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.44 | 0.007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.39 | 0.009 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |